GB9608130D0 - Adam proteins and uses thereof - Google Patents

Adam proteins and uses thereof

Info

Publication number
GB9608130D0
GB9608130D0 GBGB9608130.2A GB9608130A GB9608130D0 GB 9608130 D0 GB9608130 D0 GB 9608130D0 GB 9608130 A GB9608130 A GB 9608130A GB 9608130 D0 GB9608130 D0 GB 9608130D0
Authority
GB
United Kingdom
Prior art keywords
adam proteins
adam
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9608130.2A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sheffield
Original Assignee
University of Sheffield
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Sheffield filed Critical University of Sheffield
Priority to GBGB9608130.2A priority Critical patent/GB9608130D0/en
Publication of GB9608130D0 publication Critical patent/GB9608130D0/en
Priority to AU25727/97A priority patent/AU2572797A/en
Priority to EP97917346A priority patent/EP0894132A2/fr
Priority to PCT/GB1997/001067 priority patent/WO1997040072A2/fr
Pending legal-status Critical Current

Links

GBGB9608130.2A 1996-04-19 1996-04-19 Adam proteins and uses thereof Pending GB9608130D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB9608130.2A GB9608130D0 (en) 1996-04-19 1996-04-19 Adam proteins and uses thereof
AU25727/97A AU2572797A (en) 1996-04-19 1997-04-16 Adam proteins and uses thereof
EP97917346A EP0894132A2 (fr) 1996-04-19 1997-04-16 Proteines adam et leur utilisation
PCT/GB1997/001067 WO1997040072A2 (fr) 1996-04-19 1997-04-16 Proteines adam et leur utilisation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9608130.2A GB9608130D0 (en) 1996-04-19 1996-04-19 Adam proteins and uses thereof

Publications (1)

Publication Number Publication Date
GB9608130D0 true GB9608130D0 (en) 1996-06-26

Family

ID=10792345

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9608130.2A Pending GB9608130D0 (en) 1996-04-19 1996-04-19 Adam proteins and uses thereof

Country Status (4)

Country Link
EP (1) EP0894132A2 (fr)
AU (1) AU2572797A (fr)
GB (1) GB9608130D0 (fr)
WO (1) WO1997040072A2 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4118336B2 (ja) 1996-02-23 2008-07-16 持田製薬株式会社 メルトリン
US6265199B1 (en) 1998-07-10 2001-07-24 Zymogenetics, Inc. Disintegrin homologs
JP2002526033A (ja) * 1998-07-10 2002-08-20 ザイモジェネティクス，インコーポレイティド ディスインテグリン相同体
WO2001009189A2 (fr) 1999-07-28 2001-02-08 Genentech, Inc. Compositions et procedes de traitement de tumeurs
EP1198560B1 (fr) * 1999-08-03 2006-11-15 ZymoGenetics, Inc. Proteases a adhesion mammalienne (mapp)
DE10337368A1 (de) * 2003-08-08 2005-03-03 Technische Universität Dresden Verfahren und Mittel zur Diagnose und Behandlung von Pankreastumoren
CA2552882C (fr) * 2004-01-09 2014-08-19 Children's Medical Center Corporation Methodes de diagnostic et de pronostic de cancers d'origine epitheliale
GB0408684D0 (en) * 2004-04-19 2004-05-19 Guy S And St Thomas Hospital N Diagnostic method
WO2006014903A2 (fr) * 2004-07-27 2006-02-09 Five Prime Therapeutics, Inc. Compositions et techniques d'utilisation d'antagonistes adam12 dans le traitement de maladie
US7674597B2 (en) 2004-08-02 2010-03-09 Elan Pharmaceuticals, Inc. Signaling intermediates in an in vitro model of Alzheimer's disease
US8012947B2 (en) 2007-03-15 2011-09-06 Hospital For Special Surgery Methods and compositions for promoting wound healing
CA3056116A1 (fr) 2007-06-22 2008-12-31 Randolph Watnick Procedes et utilisations de prosaposine
WO2011084685A2 (fr) 2009-12-17 2011-07-14 Children's Medical Center Corporation Peptides dérivés de saposine a et utilisations de ceux-ci
GB2453589A (en) 2007-10-12 2009-04-15 King S College London Protease inhibition
EP3913367A1 (fr) 2008-12-30 2021-11-24 Children's Medical Center Corporation Procédé de prédiction d'une appendicite aiguë
CA2676946A1 (fr) * 2009-08-28 2011-02-28 Lucie Peduto Inhibiteurs de l'enzyme adam12 et leur utilisation contre la fibrose induite par l'inflammation
WO2011069093A1 (fr) 2009-12-04 2011-06-09 Boston Biomedical Research Institute, Inc. Détection et dénombrement de cellules souches spécifiques d'un tissu et utilisations associées
EP3560509B1 (fr) 2011-12-22 2024-01-31 Children's Medical Center Corporation Peptides dérivés de la saposine-a et leurs utilisations
US9950043B2 (en) 2012-11-15 2018-04-24 The Board Of Trustees Of The Leland Stanford Junior University Modulation of muscle and adipocyte distribution and fate
US10821155B2 (en) * 2018-06-27 2020-11-03 Juvena Therapeutics, Inc. Heparin-associated polypeptides and uses thereof
CN114569709B (zh) * 2022-05-05 2022-07-12 苏州慧疗生物医药科技有限公司 高表达adam-28的黑色素瘤自体肿瘤疫苗的制备方法及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693496A (en) * 1994-06-20 1997-12-02 Merck & Co., Inc. DNA encoding the mouse and human PH30 beta chain protein

Also Published As

Publication number Publication date
AU2572797A (en) 1997-11-12
WO1997040072A3 (fr) 1998-03-26
WO1997040072A2 (fr) 1997-10-30
EP0894132A2 (fr) 1999-02-03

Similar Documents

Publication Publication Date Title
EP1021185A4 (fr) Dihydropyrimidines et leurs emplois
EP0894807A4 (fr) COMPLEXE GPIb-LIPIDE ET SES UTILISATIONS
GB2333453B (en) Colostrinin and uses thereof
GB9608130D0 (en) Adam proteins and uses thereof
HUP9700446A3 (en) Oilsuspension-concentrate and using thereof
GR990300043T1 (en) Lactoferrin variants and uses thereof
GB9705903D0 (en) VP22 Proteins and uses thereof
GB9806806D0 (en) Peptides and uses thereof
ZA9710338B (en) Proteins
EP1140976A4 (fr) Proteines secretees et leurs utilisations
GB9614033D0 (en) Modified protein G and fragments thereof
PL331523A1 (en) Azolotrizines and azolopyrimidines
GB9423372D0 (en) Proteins and their uses
HUP9801330A3 (en) Novel pka-binding proteins and uses thereof
PL328334A1 (en) Preparation and application thereof
EP0998578A4 (fr) Sel-10 et utilisations de sel-10
ZA959762B (en) Proteins having fibrinolyic and coagulation-inhibiting properties
HUP9900068A3 (en) Fuse-switch and/or fuse-disconnector
PL341293A1 (en) Beta-lypothropin and application thereof
EP1132472A4 (fr) Nouvelle proteine et son utilisation
GB9624905D0 (en) MNGEF and homologues thereof
EP0915100A4 (fr) Nouvelle proteine
EP1141269A4 (fr) Proteines secretees et leurs utilisations
ZA971900B (en) Modified proteins
GB2352176B (en) Colostrinin and uses thereof